CANC

Tema Oncology ETF

39.84

Jun 26 • 12:38PM ET +0.34 (0.86%)

Financial Exchange Traded Fund USA NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	56.15%	Total Holdings	58	Perf Week	7.13%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	190.78M	Perf Month	4.59%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	11.54%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	40.28 -1.09%	Perf Half Y	12.38%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	23.49 69.60%	Perf YTD	14.75%
Active/Passive		Quant Type		Tags	-	Flows% 1M	4.07%	Volatility	2.63% 2.13%	Perf Year	60.02%
Dividend TTM	0.02 (0.05%)	ESG Type		Tags	-	Flows% 3M	5.41%	ATR (14)	0.87	Perf 3Y	-
Dividend Ex-Date	Dec 10, 2025	Dividend Type		Sector/Theme		Flows% YTD	40.29%	RSI (14)	67.69	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.69	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	6.16%	Flows% 3Y		Rel Volume	0.72	Prev Close	39.50
Inverse/Leveraged		Market Cap		SMA50	5.42%	Flows% 5Y		Avg Volume	30.02K	Price	39.84
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	14.07%	Trades		Volume	10,942	Change	0.86%

Jan-09-26 10:00AM	Here's Why Biotech ETFs Are Rallying Hard (Zacks)
Dec-02-25 06:00AM	Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance (Business Wire)
Nov-26-25 10:00AM	Be Thankful to These ETFs This Year (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your Finviz experience